Company Filing History:
Years Active: 1980-1983
Title: The Innovations of Roger A. Briggs
Introduction
Roger A. Briggs is an accomplished inventor based in Midland, MI (US). He has made significant contributions to the field of chemical engineering, particularly in the area of rifamycin derivatives. With a total of 2 patents, his work has had a notable impact on the industry.
Latest Patents
Briggs' latest patents include innovative processes for the adsorption and recovery of rifamycin B and rifamycin S. The first patent discloses the use of basic ion exchange resins to adsorb rifamycin B or rifamycin S from dilute solutions. This method allows for the recovery of these compounds from the resin through desorption with a suitable solvent system. His second patent outlines a process for converting rifamycin O to rifamycin S using a strong acid cation exchange resin as a catalyst, along with a solvent containing up to about 13% water to dissolve the rifamycin derivatives.
Career Highlights
Roger A. Briggs is currently employed at The Dow Chemical Company, where he continues to innovate and develop new chemical processes. His expertise in chemical engineering has positioned him as a valuable asset to his team and the company.
Collaborations
Briggs has collaborated with notable coworkers, including Jo Ann Gilpin and Patrick J. Oriel, contributing to various projects and advancements in their field.
Conclusion
Roger A. Briggs exemplifies the spirit of innovation in chemical engineering through his patents and contributions at The Dow Chemical Company. His work continues to influence the industry and pave the way for future advancements.